News
AcouSort deltar på Investerarjakten
AcouSort kommer att delta i det livesända eventet Investerarjakten den 14 oktober. Bolagets vd Torsten Freltoft kommer att presentera...
Read MoreAcouSort initiates work on the Blue4Therapy project: The first step towards the stem cell treatment of the future
AcouSort has officially initiated the Blue4Therapy project. The aim of the project is to develop a platform for purification...
Read MoreAcouSort featured in Investerarbrevet and Stockpicker
AcouSort is featured in a new article at Swedish investor sites Stockpicker and Investerarbrevet. The article “AcouSort går från...
Read MoreAcouSort initiates work on the Blue4Therapy project: The first step towards the stem cell treatment of the future
AcouSort has officially initiated the Blue4Therapy project. The aim of the project is to develop a platform for purification...
Read MoreAcouSort participates in a new important CAMP project
AcouSort will participate in yet another CAMP project. The goal is to develop a GMP-approved production of stem cells....
Read MoreInterim report Q2 2020
On August 26, AcouSort released its interim report for the second quarter of 2020. The report can be found...
Read MoreAcouSort featured in Investerarbrevet and Stockpicker
AcouSort is featured in a new article at Swedish investor sites Stockpicker and Investerarbrevet. The article “AcouSort går från...
Read MoreInterview with CEO
“The market for consumable and semi-consumable blood-plasma separation modules is estimated to grow significantly in the coming years as...
Read MoreAcouSort’s technology can streamline health care – rapidly increasing global interest
AcouSort’s technology uses soundwaves to separate cells and other particles in biological fluids, for example blood samples. The technology...
Read More